BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

803 posts

Biotech NewsAurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?

  • BioTech Health X
  • June 26, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…
0 Shares
0
0
0
0
0
0
0

Biotech NewsRAPT Therapeutics (RAPT) Poised for Massive Breakout After Reverse Split and Clinical Wins

  • BioTech Health X
  • June 25, 2025
RAPT Therapeutics, Inc. (NASDAQ:RAPT) is a clinical-stage biopharmaceutical company at the forefront of precision immunology, developing oral small…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Seres Therapeutics (MRCB) Replace Antibiotics? This Biotech’s Next Drug Could Do It

  • BioTech Health X
  • June 25, 2025
Seres Therapeutics (MRCB), based in Cambridge, Massachusetts, stands at the vanguard of the live biotherapeutics revolution. Since its…
0 Shares
0
0
0
0
0
0
0

Biotech NewsGlucoTrack (GCTK)’s Implant Could Kill Finger-Prick Testing Forever—Investors are Starting to Notice

  • BioTech Health X
  • June 25, 2025
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical technology company that has spent over two decades innovating diabetes management…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSarepta Therapeutics (SRPT) May Be the Next $200 Biotech Stock Wall Street is Watching

  • BioTech Health X
  • June 25, 2025
Founded in 1980 and headquartered in Cambridge, Massachusetts, Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a cutting-edge biotechnology company at…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street is Turning Bullish on Salarius Pharmaceuticals (SLRX)

  • BioTech Health X
  • June 24, 2025
Salarius Pharmaceuticals Inc. (NASDAQ:SLRX) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from…
0 Shares
0
0
0
0
0
0
0

Biotech NewsConduit Pharmaceuticals (CDT) Could Deliver Massive Gains

  • BioTech Health X
  • June 24, 2025
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) is a clinical-stage biopharmaceutical company that is transforming the traditional model of drug development…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Lixte Biotechnology (LIXT) Turn a $1 Stock into a Multi-Bagger in 2025?

  • BioTech Health X
  • June 24, 2025
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a pioneering clinical-stage pharmaceutical company focused on unlocking new frontiers in oncology…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAlzamend Neuro (ALZN) Could Be the Next 10x Biotech Breakout in 2025

  • BioTech Health X
  • June 24, 2025
Alzamend Neuro Inc. (NASDAQ:ALZN) is a forward-thinking clinical-stage biopharmaceutical company on a mission to revolutionize the treatment landscape…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Forgot About Teladoc (TDOC)—Here’s Why That Could Be a Huge Mistake

  • BioTech Health X
  • June 23, 2025
Teladoc Health, Inc. (NYSE: TDOC) is a global pioneer in virtual healthcare, transforming how individuals access medical, mental…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCidara Therapeutics (CDTX) Surges After Breakthrough Flu Trial—Is This the Future of Seasonal Protection?

  • BioTech Health X
  • June 23, 2025
Cidara Therapeutics, Inc. (NASDAQ:CDTX) is a San Diego-based, clinical-stage biotechnology company at the forefront of a new class…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCullgen Merger Could Make Pulmatrix (PULM) a Biotech Dark Horse

  • BioTech Health X
  • June 23, 2025
Pulmatrix Inc. (NASDAQ:PULM) is a U.S.-based clinical-stage biopharmaceutical company that has carved a unique niche in the biotech…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCapricor (CAPR) Emerges as a Top Buyout Target After Breakthrough Duchenne Data

  • BioTech Health X
  • June 23, 2025
Capricor Therapeutics Inc. (NASDAQ:CAPR) is a late-stage biotechnology company at the forefront of developing transformative cell and exosome-based…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?

  • BioTech Health X
  • June 22, 2025
CorMedix Inc. (NASDAQ: CRMD) is a commercial-stage biopharmaceutical company that has reached a rare inflection point for small-cap…
0 Shares
0
0
0
0
0
0
0

Biotech NewsScinai (SCNI) Jumps 29%—Biotech Investors Are Betting on Scinai’s Dual-Revenue Model

  • BioTech Health X
  • June 22, 2025
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) is an emerging biopharmaceutical company that operates at the intersection of cutting-edge immunology research…
0 Shares
0
0
0
0
0
0
0

Biotech NewsProtagenic (PTIX) Explodes 300% After Merger With Phytanix—Is This the Next Biotech Breakout?

  • BioTech Health X
  • June 22, 2025
Protagenic Therapeutics, Inc. (NASDAQ: PTIX) has long focused on the development of peptide-based therapeutics aimed at treating stress-related…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWindtree Therapeutics (WINT)’s Big Comeback: Will it be the Next Biotech Superstar?

  • BioTech Health X
  • June 22, 2025
Windtree Therapeutics Inc. (NASDAQ:WINT) is a clinical-stage biotechnology company at the forefront of innovation in cardiovascular medicine and…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Isn’t Paying Attention to Revelation Bio (REVB)… Yet.

  • BioTech Health X
  • June 22, 2025
Revelation Biosciences Inc. (NASDAQ:REVB) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to transforming the…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • PMV Pharmaceuticals (PMVP) Forecast 2026: One Mutation, One Oral Drug, and a Re-Rating That Could Hit Fast
  • Oncolytics (ONCY) Is a $90M “Science vs. Reality” Fight—And 2026 Is When Pelareorep Has to Win
  • Nkarta (NKTX)’s Plot Twist: From Cancer Chaos to Autoimmune “Immune Reset” Hype
  • Context (CNTX)’s Glow-Up: From “Old Thesis” to T-Cell Engager Chaos (In a Good Way)
  • The $290M Cancer Biotech With Phase 3 “Proof”: Candel (CADL)’s Viral Immunotherapy Isn’t Just a Science Fair Anymore
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • February 13, 2026
    PMV Pharmaceuticals (PMVP) Forecast 2026: One Mutation, One Oral Drug, and a Re-Rating That Could Hit Fast
    • February 13, 2026
    Oncolytics (ONCY) Is a $90M “Science vs. Reality” Fight—And 2026 Is When Pelareorep Has to Win
    • February 13, 2026
    Nkarta (NKTX)’s Plot Twist: From Cancer Chaos to Autoimmune “Immune Reset” Hype
    • February 13, 2026
    Context (CNTX)’s Glow-Up: From “Old Thesis” to T-Cell Engager Chaos (In a Good Way)
    • February 13, 2026
    The $290M Cancer Biotech With Phase 3 “Proof”: Candel (CADL)’s Viral Immunotherapy Isn’t Just a Science Fair Anymore
Recent Posts
  • Verastem (VSTM) Isn’t “Small-Cap Roulette” Anymore—It’s a Commercial Oncology Ramp With a 2026 Twist
    • February 13, 2026
  • The Market Cap Is Small, the Idea Is Huge: Can Allogene (ALLO) Make CAR-T as Easy as Ordering a Drug?
    • February 13, 2026
  • 44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline
    • February 13, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (787)
  • Uncategorized (2)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top